Alternatives to Arc Institute

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Developing oral small molecule medicines for immunological and chronic diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Advancing next-generation mRNA medicines.

Scalable, one-time curative in-vivo gene editing therapies.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Developing disease-responsive advanced therapies through programmable gene control technology.

Developing breath-based diagnostics for lung diseases.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A vertically-integrated procurement platform for the life sciences industry.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A biotechnology company developing genetic therapies for rare disorders.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing gene editing therapies to lower cholesterol.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Engineering scalable gene therapies for broader patient populations.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing novel therapies to reverse aging and extend lifespan.

Establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

A biotechnology company focused on oncology drug discovery.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Developing innovative gene therapies to preserve or restore vision in patients with retinal diseases.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

AI-powered platform for designing novel molecular structures for new medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

A de-extinction biotechnology company aiming to revive extinct species.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI-powered breast cancer detection and risk assessment solutions.

Developing an automated platform for liquid biopsy sample preparation.

AI-driven predictive modeling company focused on biology and life sciences.